BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10729170)

  • 21. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
    Coppola MA; Green WR; Rich RF
    Viral Immunol; 1996; 9(2):107-19. PubMed ID: 8822627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes.
    Zhou X; Liu T; Franksson L; Lederer E; Ljunggren HG; Jondal M
    Scand J Immunol; 1995 Jul; 42(1):66-75. PubMed ID: 7631147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of herpes simplex virus gB-specific cytotoxic T lymphocytes in TAP1-deficient mice by genetic immunization but not HSV infection.
    Paliard X; Doe B; Selby MJ; Hartog K; Lee AY; Burke RL; Walker CM
    Virology; 2001 Mar; 282(1):56-64. PubMed ID: 11259190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
    Mayrand SM; Healy PA; Torbett BE; Green WR
    Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognition of endogenous ecotropic murine leukaemia viruses by anti-AKR/Gross virus cytotoxic T lymphocytes (CTL): epitope variation in a CTL-resistant virus.
    Coppola MA; Lam TM; Strawbridge RR; Green WR
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():635-41. PubMed ID: 7534814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigen.
    Ohlén C; Kalos M; Hong DJ; Shur AC; Greenberg PD
    J Immunol; 2001 Feb; 166(4):2863-70. PubMed ID: 11160355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hierarchal utilization of different T-cell receptor Vbeta gene segments in the CD8(+)-T-cell response to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Cerottini JC; MacDonald HR
    J Virol; 1999 Nov; 73(11):9161-9. PubMed ID: 10516023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous priming for anti-viral envelope cytotoxic T lymphocytes in mice transgenic for a murine leukaemia virus envelope gene (Fv4).
    Nihrane A; Silver J
    Immunology; 1997 Feb; 90(2):219-28. PubMed ID: 9135550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxic T lymphocytes to endogenous mouse retroviruses and mechanisms of retroviral escape.
    Green WR
    Immunol Rev; 1999 Apr; 168():271-86. PubMed ID: 10399080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors.
    Ossendorp F; Mengedé E; Camps M; Filius R; Melief CJ
    J Exp Med; 1998 Mar; 187(5):693-702. PubMed ID: 9480979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens.
    Klarnet JP; Kern DE; Okuno K; Holt C; Lilly F; Greenberg PD
    J Exp Med; 1989 Feb; 169(2):457-67. PubMed ID: 2562982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.